Results 101 to 110 of about 2,414,730 (187)

Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer. [PDF]

open access: yesJ Immunother Cancer
Ghiringhelli F   +23 more
europepmc   +1 more source

Correction: Risk of ciguatoxins is shaped by Gambierdiscus community structure. [PDF]

open access: yesPLoS One
Smith KF   +14 more
europepmc   +1 more source

Immune checkpoint TIM-3 in tumor immunotherapy. [PDF]

open access: yesActa Biochim Biophys Sin (Shanghai)
Ma S, Zhu M, Ma C, Li C.
europepmc   +1 more source

Home - About - Disclaimer - Privacy